Approval · Notice of Compliance 32628 · 2024
REVOLUTION PLUS: Notice of Compliance 32628
Issued February 1, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32628
- Date
- February 1, 2024
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional claim
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REVOLUTION PLUS | 02482266 | Marketed |
Medicinal ingredients
- SELAMECTIN 60 MG per ML
- SAROLANER 10 MG per ML